Search Results - "Bjelic Radisic, V."

Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial by Bjelic-Radisic, V, Fitzal, F, Knauer, M, Steger, G, Egle, D, Greil, R, Schrenk, P, Balic, M, Singer, Ch, Exner, R, Soelkner, L, Gnant, Michael

“…The ABCSG-28 trial compared primary surgery followed by systemic therapy versus primary systemic therapy without surgery in patients with de novo stage IV BC…”
Get full text

Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective by Elfgen, Constanze, Güth, U., Gruber, G., Birrer, S., Bjelic-Radisic, V., Fleisch, M., Tausch, C. J.

“…Purpose When ipsilateral breast-tumor recurrence (IBTR) following breast-conserving surgery (BCS) occurs, the cure of a potentially life-threatening disease is…”
Get full text

International validation of the European Organisation for Research and Treatment of Cancer QLQ‐BRECON23 quality‐of‐life questionnaire for women undergoing breast reconstruction by Winters, Z. E., Afzal, M., Rutherford, C., Holzner, B., Rumpold, G., da Costa Vieira, R. A., Hartup, S., Flitcroft, K., Bjelic‐Radisic, V., Oberguggenberger, A., Panouilleres, M., Mani, M., Catanuto, G., Douek, M., Kokan, J., Sinai, P., King, M. T., Spillane, A., Snook, K., Boyle, F., French, J., Elder, E., Chalmers, B., Kabir, M., Campbell, I., Wong, A., Flay, H., Scarlet, J., Weis, J., Giesler, J., Bliem, B., Nagele, E., del Angelo, N., Andrade, V., Assump¸ão Garcia, D., Bonnetain, F., Kjelsberg, M., William‐Jones, S., Fleet, A., Hathaway, S., Elliott, J., Galea, M., Dodge, J., Chaudhy, A., Williams, R., Cook, L., Sethi, S., Turton, P., Henson, A., Gibb, J., Bonomi, R., Funnell, S., Noren, C., Ooi, J., Cocks, S., Dawson, L., Patel, H., Bailey, L., Chatterjee, S., Goulden, K., Kirk, S., Osborne, W., Harter, L., Sharif, M. A., Corcoran, S., Smith, J., Prasad, R., Doran, A., Power, A., Devereux, L., Cannon, J., Latham, S., Arora, P., Ridgway, S., Coulding, M., Roberts, R., Absar, M., Hodgkiss, T., Connolly, K., Johnson, J., Doyle, K., Lunt, N., Cooper, M., Fuchs, I., Peall, L., Taylor, L., Nicholson, A.

“…Background The aim was to carry out phase 4 international field‐testing of the European Organisation for Research and Treatment of Cancer (EORTC) breast…”
Get full text

Interdisciplinary S2k Guideline: Sonography in Urogynecology: Short Version - AWMF Registry Number: 015/055 by Tunn, R, Albrich, S, Beilecke, K, Kociszewski, J, Lindig-Knopke, C, Reisenauer, C, Schwertner-Tiepelmann, N, Kuhn, A, Viereck, V, Bjelic Radisic, V, Kölle, D, Umek, W, Bader, W, Schwandner, O, Lange, R

Get full text

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 by Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Knauer, M., Moik, M., Jakesz, R., Seifert, M., Taucher, S., Bjelic-Radisic, V., Balic, M., Eidtmann, H., Eiermann, W., Steger, G., Kwasny, W., Dubsky, P., Selim, U., Fitzal, F., Hochreiner, G., Wette, V., Sevelda, P., Ploner, F., Bartsch, R., Fesl, C., Greil, R.

“…These final results from ABCSG-12 confirm that twice-yearly ZOL safely enhances the efficacy of adjuvant endocrine therapy. Tamoxifen together with Goserelin…”
Get full text

154. Modified superior pedicle with volume replacement with inferior glandular pedicle – A case report by Bjelic-Radisic, V

Get full text

240. Short-term outcome and QoL in 108 patients after immediate breast reconstruction with implants and acellular dermis by Bjelic-Radisic, V

Get full text

An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45 by Bjelic-Radisic, V., Cardoso, F., Cameron, D., Brain, E., Kuljanic, K., da Costa, R.A., Conroy, T., Inwald, E.C., Serpentini, S., Pinto, M., Weis, J., Morag, O., Lindviksmoen Astrup, G., Tomaszweksi, K.A., Pogoda, K., Sinai, P., Sprangers, M., Aaronson, N., Velikova, G., Greimel, E., Arraras, J., Bottomley, A., Bleiker, Eveline, Bliem, Brigitte, Chie, Weichu, Creutzberg, Carien, Deville, Valerie, Duhoux, Francois, Eilf, Kirsten, Hartup, Sue, Koller, Michael, Nagele, Eva, Nicolatou-Galitis, Ourania, Oberguggenberger, Anne, Schmalz, Claudia, Winters, Zoe

“…The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one of the first disease-specific questionnaires developed in 1996 to…”
Get full text

Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction – A prospective randomized trial by Gschwantler-Kaulich, D, Schrenk, P, Bjelic-Radisic, V, Unterrieder, K, Leser, C, Fink-Retter, A, Salama, M, Singer, C

“…Abstract Background Comparative studies on the use of meshes and acellular dermal matrices (ADM) in implant-based breast reconstruction (IBBR) have not yet…”
Get full text

The impact of distinct triple-negative breast cancer subtypes on misdiagnosis and diagnostic delay by Elfgen, C., Varga, Z., Reeve, K., Moskovszky, L., Bjelic-Radisic, V., Tausch, C., Güth, U.

“…Background Triple-negative breast cancer (TNBC) includes mostly aggressive types of breast cancer with poor prognosis. Due to its growth pattern,…”
Get full text

Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes by Elfgen, C., Reeve, K., Moskovszky, L., Güth, U., Bjelic-Radisic, V., Fleisch, M., Tausch, C., Varga, Z.

“…Background Triple negative breast cancer (TNBC) harbors a heterogeneous group of carcinomas with poor prognosis and high genetic variability. As a potential…”
Get full text

Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283–288 by Bjelic-Radisic, V., Cardoso, F., Cameron, D., Brain, E., Kuljanic, K., da Costa, R.A., Conroy, T., Inwald, E.C., Serpentini, S., Pinto, M., Weis, J., Morag, O., Lindviksmoen Astrup, G., Tomaszewski, K.A., Pogoda, K., Sinai, P., Sprangers, M., Aaronson, N., Velikova, G., Greimel, E., Arraras, J., Bottomley, A.

Get full text

59: Vaginal hysterectomy versus total laparoscopic hysterectomy for benign indications: A randomized trial by Laky, R, Aigmueller, T, Bader, A, Bjelic-Radisic, V, Taumberger, N, Bornemann-Cimenti, H, Lang, P, Ralph, G, Tamussino, K

Get full text

Mesh versus acellular dermal matrix in immediate implant based breast reconstruction – a prospective randomized trial by Gschwantler-Kaulich, E, Schrenk, P, Bjelic-Radisic, V, Unterrieder, K, Leser, C, Fink-Retter, A, Salama, M, Singer, C

Get full text

Vaginal prolapse surgery with transvaginal mesh: results of the Austrian registry by Bjelic-Radisic, V., Aigmueller, T., Preyer, O., Ralph, G., Geiss, I., Müller, G., Riss, P., Klug, P., Konrad, M., Wagner, G., Medl, M., Umek, W., Lozano, P., Tamussino, K., Tammaa, A.

“…Introduction and hypothesis Several mesh repair systems for pelvic organ prolapse (POP) were introduced into clinical practice with limited data on safety,…”
Get full text

An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45 by Bjelic-Radisic, V., Bottomley, A., Cardoso, F., Cameron, D., Brain, E., Kuljanic, K., de Costa, R.A., Conroy, T., Inwald, E., Serpentini, S., Pinto, M., Weis, J., Morag, O., Guro Lindviksmoen Astrup, G., Tomaszweksi, K., Pogoda, K., Sinai, P., Sprangers, M.A.G., Aaronson, N., Greimel, E.

Get full text

Corrigendum to “Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction – A prospective randomized trial” [Eur J Surg Oncol 42 (5) (2016) 665–671] by Gschwantler-Kaulich, D, Schrenk, P, Bjelic-Radisic, V, Unterrieder, K, Leser, C, Fink-Retter, A, Salama, M, Singer, C

Get full text

Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) by Meyer-Wilmes, P., Huober, J., Untch, M., Blohmer, J.-U., Janni, W., Denkert, C., Klare, P., Link, T., Rhiem, K., Bayer, C., Reinisch, M., Bjelic-Radisic, V., Zahm, D.M., Hanusch, C., Solbach, C., Heinrich, G., Hartkopf, A.D., Schneeweiss, A., Fasching, P., Filmann, N., Nekljudova, V., Holtschmidt, J., Stickeler, E., Loibl, S.

“…The GENEVIEVE study, comparing neoadjuvant cabazitaxel versus paclitaxel in triple-negative breast cancer (TNBC) and luminal B/human epidermal growth factor…”
Get full text

Recurrence in a Schuchardt incision after Schauta-Amreich radical vaginal hysterectomy for cervical cancer by Bader, A A, Bjelic-Radisic, V, Tamussino, K F, Pristauz, G, Winter, R

“…A Schuchardt incision is frequently performed to facilitate access to the parametrium during radical vaginal hysterectomy for cervical cancer. We report an…”
Get more information

Lymphoscintigraphy for sentinel lymph node biopsy in breast cancer: do we need a delayed image? by Taumberger, N, Pernthaler, B, Schwarz, T, Bjelic-Radisic, V, Pristauz, G, Aigner, R, Tamussino, K

Get full text